Reid Robison, MD MBA 9/5/23 Reid Robison, MD MBA 9/5/23

Single-dose psilocybin treatment for MDD: A randomized clinical trial

JAMA Psychiatry | Published 5 Sep 2023

Reid Robison, MD MBA 5/18/23 Reid Robison, MD MBA 5/18/23

Case report: IM ketamine or IN esketamine as a treatment in four patients with MDD & comorbid anorexia

Front Psychiatry | Published 15 May 2023

Reid Robison, MD MBA 3/2/23 Reid Robison, MD MBA 3/2/23

J Psychoact Drugs | Published 2 Mar 2023

Reid Robison, MD MBA 2/9/23 Reid Robison, MD MBA 2/9/23

Front Psychiatry | 9 Feb 2023

Reid Robison, MD MBA 2/2/23 Reid Robison, MD MBA 2/2/23

Brain Sci | Published 2 Feb 2023

Reid Robison, MD MBA 1/16/23 Reid Robison, MD MBA 1/16/23

J Psychedelic Stud | Published 16 Jan 2023

Reid Robison, MD MBA 11/4/22 Reid Robison, MD MBA 11/4/22

J Comp Eff Res | 4 Nov 2022

Reid Robison, MD MBA 10/3/22 Reid Robison, MD MBA 10/3/22

BMC Psychiatry | Published 3 Oct 2022

Reid Robison, MD MBA 9/23/22 Reid Robison, MD MBA 9/23/22

J Affect Disord | Published 23 Sep 2022

Reid Robison, MD MBA 5/6/22 Reid Robison, MD MBA 5/6/22

J Eat Disord | Published 6 May 2022

Reid Robison, MD MBA 3/12/22 Reid Robison, MD MBA 3/12/22

Brain Sci | 12 Mar 2022